Blood, 0006-4971

Journal

  1. 2020
  2. Hoff, F. W., van Dijk, A. D., Qiu, Y. H., Ruvolo, P. P., Gerbing, R. B., Leonti, A. R., Jenkins, G. N., Gamis, A. S., Aplenc, R., Kolb, E. A., Alonzo, T., Meshinchi, S., De Bont, E., Bruggeman, S. W., Kornblau, S. M., & Horton, T. M. (2020). Heat Shock Factor 1 (HSF1-pSer326) Predicts Response to Bortezomib-Containing Chemotherapy in Pediatric AML: A COG Study. Blood. https://doi.org/10.1182/blood.2020005208
  3. Wortmann, S. B., Van Hove, J. L. K., Derks, T. G. J., Chevalier, N., Knight, V., Koller, A., Oussuren, E., Mayr, J. A., van Spronsen, F. J., Lagler, F. B., Gaughan, S., Van Schaftingen, E., & Veiga-da-Cunha, M. (2020). Treating neutropenia and neutrophil dysfunction in glycogen storage disease IB with an SGLT2-inhibitor. Blood, 136(9), 1033-1043. https://doi.org/10.1182/blood.2019004465
  4. Melchers, R. C., Willemze, R., Vermaat, J. S. P., Jansen, P. M., Daniels, L. A., Putter, H., Bekkenk, M. W., de Haas, E. R. M., Horvath, B., van Rossum, M. M., Sanders, C. J. G., Veraart, J. C. J. M., Vermeer, M. H., & Quint, K. D. (2020). Outcomes of rare patients with a primary cutaneous CD30(+) lymphoproliferative disorder developing extracutaneous disease. Blood, 135(10), 769-773. https://doi.org/10.1182/blood.2019002799
  5. Yvernogeau, L., Klaus, A., Maas, J., Morin-Poulard, I., Weijts, B., Schulte-Merker, S., Berezikov, E., Junker, J. P., & Robin, C. (2020). Multispecies RNA tomography reveals regulators of hematopoietic stem cell birth in the embryonic aorta. Blood, 136(7), 831-844. https://doi.org/10.1182/blood.2019004446
  6. 2019
  7. PLANET-2 MATISSE Collaborators, Fustolo-Gunnink, S. F., Fijnvandraat, K., van Klaveren, D., Stanworth, S. J., Curley, A., Onland, W., Steyerberg, E. W., de Kort, E., d'Haens, E. J., Hulzebos, C. V., Huisman, E. J., de Boode, W. P., Lopriore, E., & van der Bom, J. G. (2019). Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood, 134(26), 2354-2360. https://doi.org/10.1182/blood.2019000899
  8. Oortgiesen, B., Kroes, H., Scholtens, P., Hoogland, J., Dannenberg-De Keijzer, P., Siemes, C., Jansman, F., Kibbelaar, R., Veeger, N., Hoogendoorn, M., & Van Roon, E. (2019). Peripheral neuropathy and hypovitaminosis d are associated in multiple myeloma patients. Blood, 134(Suppl. 1). https://doi.org/10.1182/blood-2019-130611
  9. Berger, G., Gerritsen, M., Yi, G., Koorenhof-Scheele, T. N., Kroeze, L. I., Stevens-Kroef, M., Yoshida, K., Shiraishi, Y., van den Berg, E., Schepers, H., Huls, G., Mulder, A. B., Ogawa, S., Martens, J. H. A., Jansen, J. H., & Vellenga, E. (2019). Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern. Blood, 3(20), 3111-3122. https://doi.org/10.1182/bloodadvances.2019000518
  10. Huls, G., Chitu, D. A., Havelange, V., Jongen-Lavrencic, M., van de Loosdrecht, A. A., Biemond, B. J., Sinnige, H., Hodossy, B., Graux, C., van Marwijk Kooy, R., de Weerdt, O., Breems, D., Klein, S., Kuball, J., Deeren, D., Terpstra, W., Vekemans, M-C., Ossenkoppele, G. J., Vellenga, E., & Löwenberg, B. (2019). Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients. Blood, 1457-1464. https://doi.org/10.1182/blood-2018-10-879866
  11. Groeneveld, D., Pereyra, D., Veldhuis, Z., Adelmeijer, J., Ottens, P., Kopec, A. K., Starlinger, P., Lisman, T., & Luyendyk, J. P. (2019). Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans. Blood, 133(11), 1245-1256. https://doi.org/10.1182/blood-2018-08-869057
  12. 2018
  13. d'Amore, F., Leppa, S., da Silva, M. G., Relander, T., Lauritzsen, G. F., Brown, P. D. N., Pezzutto, A., Doorduijn, J. K., Weidmann, E., van Gelder, M., Van Hoof, A., Christiansen, I., Fagerli, U. M., Hagberg, H., Lugtenburg, P. J., Walewski, J., Wu, K. L., Demuynck, H. M., Fijnheer, R., ... Toldbod, H. (2018). Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant. Blood, 132(Suppl.1). http://www.bloodjournal.org/content/132/Suppl_1/998
  14. Fenaux, P., Platzbecker, U., Mufti, G. J., Garcia-Manero, G., Buckstein, R., Santini, V., Diez-Campelo, M., Finelli, C., Cazzola, M., Ilhan, O., Sekeres, M. A., Falantes, J. F., Arrizabalaga, B., Salvi, F., Giai, V., Vyas, P., Bowen, D., Selleslag, D., DeZern, A. E., ... List, A. F. (2018). The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions. Blood, 132. https://doi.org/10.1182/blood-2018-99-110805
  15. Amin, E. E., Bistervels, I. M., Meijer, K., Tick, L. W., Middeldorp, S., Mostard, G., van de Poel, M., Serne, E. H., Otten, H. M., Klappe, E. M., Joore, M. A., ten Cate, H., ten Wolde, M., & ten Cate-Hoek, A. J. (2018). Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis. Blood, 132(21), 2298-2304. https://doi.org/10.1182/blood-2018-03-836783
  16. Heitink-Pollé, K. M. J., Uiterwaal, C. S. P. M., Porcelijn, L., Tamminga, R. Y. J., Smiers, F. J., van Woerden, N. L., Wesseling, J., Vidarsson, G., Laarhoven, A. G., de Haas, M., & Bruin, M. C. A. (2018). Intravenous immunoglobulin versus observation in childhood immune thrombocytopenia: A randomized controlled trial. Blood, 132(9), 883-891. https://doi.org/10.1182/blood-2018-02-830844
  17. Cucchi, D. G. J., Denys, B., Kaspers, G. J. L., Janssen, J. J. W. M., Ossenkoppele, G. J., de Haas, V., Zwaan, C. M., van den Heuvel-Eibrink, M. M., Philippe, J., Csikos, T., Kwidama, Z., de Moerloose, B., de Bont, E. S. J. M., Lissenberg-Witte, B. I., Zweegman, S., Verwer, F., Vandepoele, K., Schuurhuis, G. J., Sonneveld, E., & Cloos, J. (2018). RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML. Blood, 131(22), 2485-2489. https://doi.org/10.1182/blood-2017-12-819508
  18. Schrader, A. M. R., Jansen, P. M., Willemze, R., Vermeer, M. H., Cleton-Jansen, A-M., Somers, S. F., Veelken, J. H. H., van Eijk, R., Kraan, W., Kersten, M. J., van den Brand, M., Stevens, W. B. C., de Jong, D., Abdul Hamid, M., Tanis, B. C., Posthuma, E. F. M., Nijland, M., Diepstra, A., Pals, S. T., ... Vermaat, J. S. P. (2018). High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma. Blood, 131(18), 2086-2089. https://doi.org/10.1182/blood-2017-12-822817
  19. Viganò, E., Gunawardana, J., Mottok, A., Van Tol, T., Mak, K., Chan, F. C., Chong, L., Chavez, E., Woolcock, B., Takata, K., Twa, D., Shulha, H. P., Telenius, A., Kutovaya, O., Hung, S. S., Healy, S., Ben-Neriah, S., Leroy, K., Gaulard, P., ... Steidl, C. (2018). Somatic IL4R Mutations in Primary Mediastinal Large B-cell lymphoma lead to constitutive JAK-STAT signaling activation. Blood, 131(18), 2036-2046. https://doi.org/10.1182/blood-2017-09-808907
  20. Berger, G., Kroeze, L. I., Koorenhof-Scheele, T. N., de Graaf, A. O., Yoshida, K., Ueno, H., Shiraishi, Y., Miyano, S., van den Berg, E., Schepers, H., van der Reijden, B. A., Ogawa, S., Vellenga, E., & Jansen, J. H. (2018). Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT. Blood, 131(16), 1846-1857. https://doi.org/10.1182/blood-2017-09-805879
  21. Miesbach, W., Meijer, K., Coppens, M., Kampmann, P., Klamroth, R., Schutgens, R., Tangelder, M., Castaman, G., Schwaeble, J., Bonig, H., Seifried, E., Cattaneo, F., Meyer, C., & Leebeek, F. W. G. (2018). Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B. Blood, 131(9), 1022-1031. https://doi.org/10.1182/blood-2017-09-804419
  22. Aukema, S. M., Hoster, E., Rosenwald, A., Canoni, D., Delfau-Larue, M-H., Rymkiewicz, G., Thorns, C., Hartmann, S., Kluin-Nelemans, H., Hermine, O., Dreyling, M., & Klapper, W. (2018). Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. Blood, 131(4), 417-420. https://doi.org/10.1182/blood-2017-07-797019
  23. Cany, J., Roeven, M. W. H., Evert, J. S. H., Hobo, W., Maas, F., Fernandez, R. F., Blijlevens, N. M. A., van der Velden, W. J., Huls, G., Jansen, J. H., Schaap, N. P. M., & Dolstra, H. (2018). Decitabine enhances targeting of AML cells by CD34(+) progenitor-derived NK cells in NOD/SCID/IL2Rg(null) mice. Blood, 131(2), 202-214. https://doi.org/10.1182/blood-2017-06-790204
  24. 2017
  25. Mai, E. K., Hielscher, T., Bertsch, U., Schlenzka, J., Salwender, H. J., Lokhorst, H. M., Munder, M., van der Holt, B., Gerecke, C., Pfreundschuh, M., Duhrsen, U., Brossart, P., Zweegman, S., Neben, K., Hillengass, J., Raab, M-S. S., Hose, D., Vellenga, E., Merz, M., ... Goldschmidt, H. (2017). A Predictive Score for Early Mortality during Induction Therapy in Newly Diagnosed Transplant-Eligible Multiple Myeloma - an Analysis from Five GMMG and HOVON Multicenter Phase III Trials. Blood, 130.
  26. Wester, R., van der Holt, B., Asselbergs, E., Zweegman, S., Kersten, M. J., Vellenga, E., Kooij, M. V. M., de Weerdt, O., Minnema, M. C., Lonergan, S., Palumbo, A., Lokhorst, H. M., Broyl, A., Iskander, K. S., & Sonneveld, P. (2017). Carfilzomib Combined with Thalidomide and Low-Dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma: The Carthadex Trial. Blood, 130.
  27. Fenaux, P., Raza, A., Vellenga, E., Platzbecker, U., Santini, V., Samarina, I., Van Eygen, K., Diez-Campelo, M., Patnaik, M. M., Sherman, L., Sun, L., Varsos, H., Rose, E., Rizo, A., & Steensma, D. P. (2017). Efficacy and Safety of Imetelstat in RBC Transfusion-Dependent (TD) IPSS Low/Int-1 MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agents (ESA) (IMerge). Blood, 130.
  28. Somers, S., Jansen, P., Veelken, H., Vermeer, M., Kraan, W., Schrader, A-R., Posthuma, W., Nijland, M., Diepstra, A., Kersten, M. J., Pals, S., Cleven, A., & Vermaat, J. (2017). High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Bruton's Kinase Inhibitors? Blood, 130.
  29. Huls, G., Chitu, D., Havelange, V., Jongen-Lavrencic, M., van de Loosdrecht, A., Biemond, B. J., Sinnege, H., Hodossy, B., Graux, C., Kooij, M. V. M., de Weerdt, O., Breems, D., Klein, S., Kuball, J., Ossenkoppele, G. J., Lowenberg, B., & Vellenga, E. (2017). Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15). Blood, 130.
  30. Aldenhoven, M., van den Broek, B. T. A., Wynn, R. F., O'Meara, A., Veys, P., Rovelli, A., Jones, S. A., Parini, R., van Hasselt, P. M., Renard, M., Bordon, V., de Koning, T. J., & Boelens, J. J. (2017). Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation. Blood, 1(24), 2236-2242. https://doi.org/10.1182/bloodadvances.2017011387
  31. Martín-Pardillos, A., Tsaalbi-Shtylik, A., Chen, S., Lazare, S., van Os, R. P., Dethmers-Ausema, A., Fakouri, N. B., Bosshard, M., Aprigliano, R., van Loon, B., Salvatori, D. C. F., Hashimoto, K., Dingemanse-van der Spek, C., Moriya, M., Rasmussen, L. J., de Haan, G., Raaijmakers, M. H. G. P., & de Wind, N. (2017). Genomic and functional integrity of the hematopoietic system requires tolerance of oxidative DNA lesions. Blood, 130(13), 1523-1534. https://doi.org/10.1182/blood-2017-01-764274
  32. Vavassori, S., Galson, J. D., Trück, J., van den Berg, A., Tamminga, R. Y. J., Magerus-Chatinet, A., Pellé, O., Camenisch Gross, U., Marques Maggio, E., Prader, S., Opitz, L., Nüesch, U., Mauracher, A., Volkmer, B., Speer, O., Suda, L., Röthlisberger, B., Zimmermann, D. R., Müller, R., ... Pachlopnik Schmid, J. (2017). Lymphadenopathy driven by TCR-Vγ8Vδ1 T-cell expansion in FAS-related autoimmune lymphoproliferative syndrome. Blood, 1(15), 1101-1106. https://doi.org/10.1182/bloodadvances.2017006411
  33. Lowenberg, B., Pabst, T., Maertens, J., van Norden, Y., Biemond, B. J., Schouten, H. C., Spertini, O., Vellenga, E., Graux, C., Havelange, V., de Greef, G. E., de Weerdt, O., Legdeur, M-C. J. C., Kuball, J., Kooy, M. V. M., Gjertsen, B. T., Jongen-Lavrencic, M., de Loosdrecht, A. A. V., van Lammeren-Venema, D., ... Swiss Grp Clinical Canc Res (2017). Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML. Blood, 129(12), 1636-1645. https://doi.org/10.1182/blood-2016-10-740613
  34. Valerio, D. G., Xu, H., Eisold, M. E., Woolthuis, C. M., Pandita, T. K., & Armstrong, S. A. (2017). Histone acetyltransferase activity of MOF is required for adult but not early fetal hematopoiesis in mice. Blood, 129(1), 48-59. https://doi.org/10.1182/blood-2016-05-714568
Previous 1 2 3 4 5 6 7 8 Next

ID: 1461464